155 related articles for article (PubMed ID: 15032183)
21. [Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia].
Kornhuber J
Fortschr Neurol Psychiatr; 2004 Oct; 72(10):553-4. PubMed ID: 15472777
[No Abstract] [Full Text] [Related]
22. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
23. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
[No Abstract] [Full Text] [Related]
24. [Alzheimer type dementia].
Ruis J
Rev Infirm; 2008 Sep; (143):14-5. PubMed ID: 18788658
[No Abstract] [Full Text] [Related]
25. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
26. Delaying Alzheimer's. In a new study, Aricept held it off for 18 months. Is this drug right for you?
Gupta S
Time; 2004 Aug; 164(5):84. PubMed ID: 15357465
[No Abstract] [Full Text] [Related]
27. Alzheimer disease. Donepezil and nursing home placement--benefits and costs.
Jelic V; Winblad B
Nat Rev Neurol; 2016 Jan; 12(1):11-3. PubMed ID: 26714658
[TBL] [Abstract][Full Text] [Related]
28. FDA is criticised for licensing high dose donepezil.
Lenzer J
BMJ; 2011 May; 342():d3270. PubMed ID: 21613347
[No Abstract] [Full Text] [Related]
29. How the FDA forgot the evidence: the case of donepezil 23 mg.
Schwartz LM; Woloshin S
BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
[No Abstract] [Full Text] [Related]
30. Donepezil in the treatment of patients with Alzheimer's disease.
Tsuno N
Expert Rev Neurother; 2009 May; 9(5):591-8. PubMed ID: 19402770
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
32. Donepezil in severe Alzheimer's disease.
Winblad B
Am J Alzheimers Dis Other Demen; 2009; 24(3):185-92. PubMed ID: 19246572
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy, efficiency and evidence -- studies on donepezil].
Wallesch CW; Ebert AD
Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778
[No Abstract] [Full Text] [Related]
34. Refining treatment guidelines in Alzheimer's disease.
Doody RS
Geriatrics; 2005 Jun; Suppl():14-20. PubMed ID: 16025771
[TBL] [Abstract][Full Text] [Related]
35. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
Harry RD; Zakzanis KK
Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
[TBL] [Abstract][Full Text] [Related]
36. Incidence of cholinergic and memantine treatment in Alzheimer's disease in Finland.
Virta L; Viramo P
J Am Geriatr Soc; 2007 Nov; 55(11):1886-7. PubMed ID: 17979907
[No Abstract] [Full Text] [Related]
37. [Relief for caregivers. Anti-dementia drug saves costs].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697297
[No Abstract] [Full Text] [Related]
38. Discontinuing Alzheimer's disease drug therapy: why, when, and how.
Crutchfield D
Director; 2008; 16(1):19-21. PubMed ID: 19343870
[TBL] [Abstract][Full Text] [Related]
39. Drug therapy of dementia in elderly patients. A review.
Olsen CE; Poulsen HD; Lublin HK
Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
